Usefulness of Measuring Serum Procalcitonin Levels in Patients with Inflammatory Bowel Disease
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background/Aims: The relationships between serum procalcitonin, inflammatory bowel disease (IBD) and intestinal Behçet’s disease (BD) have not been completely determined. We aimed to evaluate the usefulness of measuring serum procalcitonin levels to assess disease activity and infection stage in patients with IBD and intestinal BD. Methods: We retrospectively analyzed clinical data from 129 patients with IBD and intestinal BD for whom serum procalcitonin and Creactive protein (CRP) levels were measured between January 2006 and February 2013. Results: The median serum procalcitonin levels in the IBD and intestinal BD with septic shock or sepsis (n=8), with localized infection (n=76), and without infection (n=45) were 3.46 ng/mL (range, 0.17 to 63.66 ng/mL), 0.22 ng/mL (range, 0.05 to 140.18 ng/mL), and 0.07 ng/mL (range, 0.00 to 31.50 ng/mL), respectively (p=0.001). The serum CRP levels in the IBD and intestinal BD patients did not differ according to the infection stage. Variations in serum procalcitonin levels were not observed in the IBD and intestinal BD patients with different disease activities. Conclusions: Serum procalcitonin levels may not be affected by IBD and intestinal BD activity itself, although they may be affected by concomitant infection. Serum procalcitonin measurements could be more useful than CRP in determining the infection stage that reflects the severity of infection in IBD and intestinal BD patients.
Abstract
Background/Aims: The relationships between serum procalcitonin, inflammatory bowel disease (IBD) and intestinal Behçet’s disease (BD) have not been completely determined. We aimed to evaluate the usefulness of measuring serum procalcitonin levels to assess disease activity and infection stage in patients with IBD and intestinal BD. Methods: We retrospectively analyzed clinical data from 129 patients with IBD and intestinal BD for whom serum procalcitonin and Creactive protein (CRP) levels were measured between January 2006 and February 2013. Results: The median serum procalcitonin levels in the IBD and intestinal BD with septic shock or sepsis (n=8), with localized infection (n=76), and without infection (n=45) were 3.46 ng/mL (range, 0.17 to 63.66 ng/mL), 0.22 ng/mL (range, 0.05 to 140.18 ng/mL), and 0.07 ng/mL (range, 0.00 to 31.50 ng/mL), respectively (p=0.001). The serum CRP levels in the IBD and intestinal BD patients did not differ according to the infection stage. Variations in serum procalcitonin levels were not observed in the IBD and intestinal BD patients with different disease activities. Conclusions: Serum procalcitonin levels may not be affected by IBD and intestinal BD activity itself, although they may be affected by concomitant infection. Serum procalcitonin measurements could be more useful than CRP in determining the infection stage that reflects the severity of infection in IBD and intestinal BD patients.
참고문헌 (34)
- Jung YS, "Expression of a soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) correlates with clinical disease activity in intestinal Behcet’s disease", Inflamm Bowel Dis, 17, pp.2130~2137 (2011)
- Park JJ, "Correlation of serum-soluble triggering receptor expressed on myeloid cells-1 with clinical disease activity in inflammatory bowel disease", Dig Dis Sci, 54, pp.1525~1531 (2009)
- 김경옥, "Does Carotid Intima-Media Thickness Increase in Patients With Inflammatory Bowel Disease?", Intestinal research, 12(4), pp.293~298 (2014), 대한장연구학회
- Lidar M, "The role of infection in inflammatory bowel disease: initiation, exacerbation and protection", Isr Med Assoc J, 11, pp.558~563 (2009)
- 박재준, "Outcome Predictors for Intestinal Behçet’s Disease", Yonsei Medical Journal, 54(5), pp.1084~1090 (2013), 연세대학교의과대학[DOI]
- 주고운, "Serum Procalcitonin for Differentiating Bacterial Infection from Disease Flares in Patients with Autoimmune Diseases", Journal of Korean Medical Science, 26(9), pp.1147~1151 (2011), 대한의학회
- Le Moullec JM, "The complete sequence of human preprocalcitonin", FEBS Lett, 167, pp.93~97 (1984)
- Whicher J, "Procalcitonin as an acute phase marker", Ann Clin Biochem, 38(5), pp.483~493 (2001)
- Müller CA, "Role of procalcitonin and granulocyte colony stimulating factor in the early prediction of infected necrosis in severe acute pancreatitis", Gut, 46, pp.233~238 (2000)
- Uzzan B, "Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis", Crit Care Med, 34, pp.1996~2003 (2006)
- Oruç N, "Diagnostic value of serum procalcitonin in determining the activity of inflammatory bowel disease", Turk J Gastroenterol, 20, pp.9~12 (2009)
- Floriańczyk B, "Structure and diagnostic value of procalcitonin", Ann Univ Mariae Curie Sklodowska Med, 58, pp.338~342 (2003)
- Cheon JH, "Development and validation of novel diagnostic criteria for intestinal Behçet’s disease in Korean patients with ileocolonic ulcers", Am J Gastroenterol, 104, pp.2492~2499 (2009)
- Lennard-Jonesa JE, "Classification of inflammatory bowel disease", Scand J Gastroenterol, 24(170), pp.2~6 (1989)
- Kornbluth A, "Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee", Am J Gastroenterol, 99, pp.1371~1385 (2004)
- Hanauer SB, "Management of Crohn’s disease in adults", Am J Gastroenterol, 96, pp.635~643 (2001)
- Cheon JH, "Development, validation, and responsiveness of a novel disease activity index for intestinal Behçet’s disease", Inflamm Bowel Dis, 17, pp.605~613 (2011)
- Bone RC, "Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP", SCCM Consensus Conference Committee. American College of Chest Physicians, Chest, pp.1992, 101[DOI]
- Gibot S, "Plasma level of a triggering receptor expressed on myeloid cells-1: its diagnostic accuracy in patients with suspected sepsis", Ann Intern Med, 141, pp.9~15 (2004)
- Nijsten MW, "Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro", Crit Care Med, 28, pp.458~461 (2000)
- Gabay C, "Acute-phase proteins and other systemic responses to inflammation", N Engl J Med, 340, pp.448~454 (1999)
- Eberhard OK, "Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus", systemic antineutrophil cytoplasmic antibodyassociated vasculitis) and invasive bacterial infection, 1997, pp.40, 1250~1256
- Oczenski W, "Procalcitonin: a new parameter for the diagnosis of bacterial infection in the peri-operative period", Eur J Anaesthesiol, 15, pp.202~209 (1998)
- Korczowski B, "Serum procalcitonin and C-reactive protein in children with diarrhoea of various aetiologies", Acta Paediatr, 93, pp.169~173 (2004)
- Gattas DJ, "Procalcitonin as a diagnostic test for sepsis:health technology assessment in the ICU", J Crit Care, 18, pp.52~58 (2003)
- Limper M, "The diagnostic role of procalcitonin and other biomarkers in discriminating infectious from non-infectious fever", J Infect, 60, pp.409~416 (2010)
- Delèvaux I, "Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes?", Ann Rheum Dis, 62, pp.337~340 (2003)
- Meynaar IA, "In critically ill patients, serum procalcitonin is more useful in differentiating between sepsis and SIRS than CRP, IL-6, or LBP", Crit Care Res Pract, 2011, pp.594645~ (2011)
- Simon L, "Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis", Clin Infect Dis, 39, pp.206~217 (2004)
- Herrlinger KR, "Serum procalcitonin differentiates inflammatory bowel disease and self-limited colitis", Inflamm Bowel Dis, 10, pp.229~233 (2004)
- Oussalah A, "Additional benefit of procalcitonin to C-reactive protein to assess disease activity and severity in Crohn’s disease", Aliment Pharmacol Ther, 32, pp.1135~1144 (2010)
- Koido S, "Clinical significance of serum procalcitonin in patients with ulcerative colitis", World J Gastroenterol, 19, pp.8335~8341 (2013)
- Thia KT, "Role of procalcitonin in infectious gastroenteritis and inflammatory bowel disease", Dig Dis Sci, 53, pp.2960~2968 (2008)
- Adam B, "Serum interleukin-6, procalcitonin and Creactive protein levels in subjects with active Behçet’s disease", J Eur Acad Dermatol Venereol, 18, pp.318~320 (2004)